ScreenerHero

ICCC ImmuCell Corporation

NAS · US · Healthcare · Biotechnology · immucell.com
9.690USD-2.81%Mkt Cap: 88.01M $P/E: 138.43

ImmuCell Corporation, an animal health company, develops, manufactures, and sells products that improves the health and productivity of dairy and beef cattle in the United States and internationally. It operates through …

Industry Peers

Biotechnology
Screen all
VRTX
Vertex Pharmaceuticals Incorporated
$128.08BUSDP/E 29.4
MRNA
Moderna, Inc.
$78.44BUSD
REGN
Regeneron Pharmaceuticals, Inc.
$76.40BUSDP/E 18.4
ARGX
argenx SE
$57.03BUSDP/E 37.3
ARGX
argenx SE
$58.08BUSDP/E 35.4
UCB
UCB SA
$42.24BUSDP/E 18.0
RVMD
Revolution Medicines, Inc.
$43.05BUSD
ONC
BeOne Medicines AG
$41.41BUSDP/E 65.1
RPRX
Royalty Pharma plc
$32.80BUSDP/E 30.2
ALNY
Alnylam Pharmaceuticals, Inc.
$30.03BUSDP/E 37.8
ROIV
Roivant Sciences Ltd.
$25.10BUSD
BNTX
BioNTech SE
$23.93BUSD
GMAB
Genmab A/S
$22.27BUSDP/E 30.7
INCY
Incyte Corporation
$22.99BUSDP/E 14.5
GMAB
Genmab A/S
$22.54BUSDP/E 28.9
INSM
Insmed Incorporated
$22.22BUSD
ASND
Ascendis Pharma A/S
$15.03BUSDP/E 17.5
JAZZ
Jazz Pharmaceuticals plc
$15.01BUSDP/E 15.8
EXEL
Exelixis, Inc.
$14.48BUSDP/E 18.4
SMMT
Summit Therapeutics Inc.
$14.32BUSD

Key Statistics

Company
Market Cap88.01M USD
Enterprise Value94.14M USD
Revenue (TTM)30.68M USD
Gross Profit11.45M USD
Net Income (TTM)-1.04M USD
Revenue/Share3.39 USD
Last Price9.690 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees73
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)138.43
P/E (Forward)-90.64
PEG—
EV/EBITDA13.35
EV/Revenue3.07
P/S2.95
P/B2.89
EPS (TTM)0.07
EPS (Forward)-0.11
52W Range
4.52068% of range12.10
52W High12.10 USD
52W Low4.520 USD
Profitability
Gross Margin41.40%
Oper. Margin26.93%
EBITDA Margin22.99%
Profit Margin-3.76%
ROE-3.84%
ROA-2.45%
Growth
Revenue Growth11.50%
Earnings Growth259.90%
Cash Flow & Leverage
Operating CF2.48M USD
CapEx (TTM)1.25M USD
FCF Margin10.05%
FCF Yield3.50%
Net Debt3.59M USD
Net Debt/EBITDA0.51
Balance Sheet
Debt/Equity0.49
Current Ratio4.75
Quick Ratio2.65
Book Value/Sh3.46 USD
Cash/Share0.98 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:100
Split DateJul 25, 1990
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.9.08M
Float6.03M
Insiders32.09%
Institutions20.30%
Short Interest
Short Ratio0.8d
Short % Float0.26%
Short % Out.0.22%
Shares Short19.83K
Short (prev mo.)15.22K
Technical
SMA 5010.19 (-4.9%)
SMA 2008.493 (+14.1%)
Beta0.57
S&P 52W Chg16.45%
Avg Vol (30d)16.79K
Avg Vol (10d)8.24K
Technical Indicators
RSI (14)42.4
MACD-0.1195
MACD Signal-0.1331
MACD Hist.+0.0136
BB Upper10.14 USD
BB Middle9.858 USD
BB Lower9.581 USD
BB Width5.63%
ATR (14)0.2777 USD
Vol Ratio (20d)0.44x